$8.12
1.1516.5%
Last update: Nov 5, 9:06 AM
Precision BioSciences Inc
DTILNASDAQ
The average analyst price target for Precision BioSciences is $37.17, 332.2% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $19 to $60. The latest change came on Jun 9, 2026, when Oppenheimer initiated coverage of Precision BioSciences with an Outperform rating and a $20 price target.
Price Target Range — 7 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
